BSE · VINRKLB
Rekvina Laboratories Ltd
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,784
of 5,034 stocks
▲ 101W
Peak #3,711 · 21 Sep 2026
Rekvina Laboratories Ltd, a microcap Healthcare business, is growing revenue rapidly, generates a high return on equity, and remains firmly promoter-controlled, with promoters holding 77%.
Market Cap
30.44 Cr
P/E Ratio
—
P/B Ratio
—
ROE
20.74%
ROCE
20.74%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 66.85 L | 72.36 L | 34.56 L | 19.62 L |
| Net Profit | -12.05 L | -6.05 L | -12.39 L | -3.49 L |
| EPS | 0.20 | -0.10 | 0.21 | -0.06 |
| Operating Profit | -12.05 L | -6.05 L | -12.39 L | -3.49 L |
Shareholding pattern
Promoter
77.00%
Public
23.00%
PUBLIC BREAKDOWN
Individuals
18.97%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 30 Apr 2014 | Split | Stock Split From Rs.10/- to Rs.5/- |
| 04 Sep 2003 | Dividend | NIL Dividend - Rs. - 0.0000 |
| 04 Sep 2002 | Dividend | NIL Dividend - Rs. - 0.0000 |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.